Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 09:50 ET | Source: SNS Insider pvt ltd

Plasmid Purification Market to Reach USD 4.74 Billion by 2032, Driven by Expanding Gene Therapy and Vaccine Applications – SNS Insider

Austin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Plasmid Purification Market Size & Growth Analysis According to SNS Insider, the global Plasmid Purification Market was valued at USD 1.96 billion in...
November 03, 2025 07:05 ET | Source: uniQure Inc.

uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
October 31, 2025 08:06 ET | Source: Research and Markets

Asia-Pacific Cell Sheet-based Gene Therapy Market Trends and Growth Outlook 2025-2035 - Increasing Focus on Personalized Medicine and Precision Therapies is Creating Demand for Novel Cell-based Platforms

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country -...
October 31, 2025 08:03 ET | Source: Research and Markets

Europe Cell Sheet-based Gene Therapy Market Analysis and Forecast, 2025-2035 - Favorable Regulatory Framework Under EMA's Advanced Therapy Medicinal Products (ATMP) Pathway

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Europe Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country - Analysis...
October 30, 2025 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of...
October 28, 2025 09:45 ET | Source: SNS Insider pvt ltd

Transfection Reagents & Equipment Market Size to Reach USD 2.54 Billion by 2032 Growing at CAGR of 8.12% - SNS Insider

Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Transfection Reagents & Equipment Market Size & Growth Analysis: According to SNS Insider, the global Transfection Reagents & Equipment Market...
October 28, 2025 08:05 ET | Source: Research and Markets

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Cell and Gene Therapy Third-Party Logistics Market Report by Type, Product, Therapeutic Area, End Use, States and Company Analysis,...
October 28, 2025 08:00 ET | Source: SparingVision

SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial

SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity and aspects of color vision by creating an...
October 24, 2025 09:30 ET | Source: SNS Insider pvt ltd

Cell Banking Outsourcing Market Size Projected to Hit USD 49.9 Billion by 2032 – SNS Insider

Austin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cell Banking Outsourcing Market Size & Growth Analysis: According to SNS Insider, the Cell Banking Outsourcing Market is valued at USD 12.5 billion...
October 23, 2025 07:30 ET | Source: Ocugen

Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results

MALVERN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...